LISA POULOS: Open Payments
NPI 1174561740 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 87 payments from 18 companies in 2025. Trend: 2023 $2,249 · 2024 $1,560 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $300 |
| Otsuka America Pharmaceutical, Inc. | 14 | $195 |
| Alkermes, Inc. | 14 | $186 |
| ABBVIE INC. | 14 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $124 |
| Lundbeck LLC | 6 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| Tris Pharma Inc | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: INGREZZA, VRAYLAR, ARISTADA, REXULTI, CAPLYTA, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
